GSK2983559
Based on 2 publication(s) in Google Scholar
GSK2983559 is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.49%
- Formel: C21H23N4O7PS2.1/2Ca.3H2O
- Molecular Weight:612.63
-
Speicherung:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) GSK2983559
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
RIPK2 |
In Vitro
GSK2983559 (1-1024 nM; 2 h) blocks MDP-induced IL-8 in THP-1 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:THP-1 cells
-
Concentration:1-1024 nM
-
Incubation Time:2 hours
-
Result:Inhibited IL-8 production with an IC50 of 1.34 nM.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 mice (female) injected with MDP (100 μg)[2]
-
Dosage:3 and 10 mg/kg
-
Administration:Oral gavage; 3 and 10 mg/kg; once
-
Result:Suppressed serum IL-6 levels in a dose-dependent manner.
Chemical Information
-
Appearance Solid
-
Molecular Weight 612.63
-
Formel C21H23N4O7PS2.1/2Ca.3H2O
-
Color Yellow to brown
-
SMILES
CC(C)(C)S(C(C(OCCOP(O)([O-])=O)=CC1=NC=N2)=CC1=C2NC3=CC(N=CS4)=C4C=C3)(=O)=O.[H]O[H].[H]O[H].[H]O[H].[Ca+2]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (2)
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : < 1 mg/mL (insoluble or slightly soluble)
DMF : < 1 mg/mL (insoluble)
Ethanol : < 1 mg/mL (insoluble)
* GSK2983559 is usually formulated as a suspension.
Reinheit & Dokumentation
-
Data Sheet (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Pamela A Haile, et al. Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases. J Med Chem. 2019 Jul 25;62(14):6482-6494. [Content Brief]
[2]. Shuwei Wu, et al. Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors. Bioorg Med Chem Lett. 2022 Sep 2;75:128968. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
GSK2983559 Related Classifications
HY-112038A Related Classifications
Powered by Bioz